產(chǎn)品屬性：
產(chǎn)品名稱(chēng) | Rineterkib hydrochloride |
規(guī)格 | 5 mg、10 mg、25 mg |
貨號(hào) | EY-01Y16861 |
Cas No.: 1715025-34-5
別名: N/A
化學(xué)名: N/A
分子式: C26H27BrF3N5O2.xClH
分子量: N/A
溶解度: DMSO : 220 mg/mL (Need ultrasonic)
儲(chǔ)存條件: 4°C, away from moisture and light
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述：
Rineterkib hydrochloride (compound B) is an orally active RAF and ERK1/2 inhibitor in the treatment of a proliferative disease characterized by activating mutations in the MAPK pathway. The activity is particularly related to the treatment of KRAS-mutant NSCLC, BRAF-mutant NSCLC, KRAS-mutant pancreatic cancer, KRAS-mutant colorectal cancer (CRC) and KRAS-mutant ovarian cancer[1].ERK-IN-1 (compound B) (50, 75 mg/kg, p.o., qd/q2d, 27 days) treatment significantly reduces the tumor volume in the Calu-6 human NSCLC subcutaneous tumor xenograft model in mice[1].[1]. CAPONIGRO, et al. THERAPEUTIC COMBINATIONS COMPRISING A RAF INHIBITOR AND A ERK INHIBITOR. WO2018051306A1.
特別提醒公司產(chǎn)品僅供科研使用
